These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19011603)

  • 1. Diabetic macular oedema and erythropoietin.
    Uparkar M; Kaul S
    Eye (Lond); 2009 Aug; 23(8):1747-8; author reply 748. PubMed ID: 19011603
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema.
    García-Arumí J; Fonollosa A; Macià C; Hernandez C; Martinez-Castillo V; Boixadera A; Zapata MA; Simo R
    Eye (Lond); 2009 May; 23(5):1066-71. PubMed ID: 18670462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
    Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
    Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pathogenic candidates for diabetic macular edema detected by proteomic analysis.
    Hernández C; García-Ramírez M; Colomé N; Villarroel M; Corraliza L; García-Pacual L; Casado J; Canals F; Simó R
    Diabetes Care; 2010 Jul; 33(7):e92. PubMed ID: 20587712
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does vitrectomy affect diabetic macular edema?
    Stefánsson E; Landers MB
    Am J Ophthalmol; 2006 May; 141(5):984; author reply 984-5. PubMed ID: 16678538
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
    Sander B; Larsen M; Moldow B; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating diabetic retinopathy by inhibiting growth factor pathways.
    Frank RN
    Curr Opin Investig Drugs; 2009 Apr; 10(4):327-35. PubMed ID: 19337953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
    Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA
    Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process.
    Ehrlich R; Harris A; Ciulla TA; Kheradiya N; Winston DM; Wirostko B
    Acta Ophthalmol; 2010 May; 88(3):279-91. PubMed ID: 20222885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
    Nguyen QD; Tatlipinar S; Shah SM; Haller JA; Quinlan E; Sung J; Zimmer-Galler I; Do DV; Campochiaro PA
    Am J Ophthalmol; 2006 Dec; 142(6):961-9. PubMed ID: 17046701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema.
    Jonas JB; Neumaier M
    Ophthalmic Res; 2007; 39(3):139-42. PubMed ID: 17505145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravitreal triamcinolone for diabetic macular oedema. Method and complications].
    Zamfir C
    Oftalmologia; 2009; 53(1):100-5. PubMed ID: 19569613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography: a key to the future management of patients with diabetic macular oedema.
    Massin P; Girach A; Erginay A; Gaudric A
    Acta Ophthalmol Scand; 2006 Aug; 84(4):466-74. PubMed ID: 16879566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiopathy and the eye].
    Rencová E
    Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of vitreous from diabetic macular edema.
    Ouchi M; West K; Crabb JW; Kinoshita S; Kamei M
    Exp Eye Res; 2005 Aug; 81(2):176-82. PubMed ID: 16080911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema.
    Audren F; Tod M; Massin P; Benosman R; Haouchine B; Erginay A; Caulin C; Gaudric A; Bergmann JF
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3435-41. PubMed ID: 15452046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.
    Krepler K; Biowski R; Schrey S; Jandrasits K; Wedrich A
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):735-8. PubMed ID: 12271370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laser treatment of diabetic macular edema].
    Hendrikse F
    Bull Soc Belge Ophtalmol; 1993; 247(1):57-8. PubMed ID: 8205338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
    Shimada H; Akaza E; Yuzawa M; Kawashima M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.